Weiss Asset Management reports 0 shares in Semler Scientific (NASDAQ: SMLR)

Rhea-AI Filing Summary

Semler Scientific, Inc. (SMLR) is the subject of an amended Schedule 13G/A filed by Weiss Asset Management, WAM GP LLC and Andrew M. Weiss. The amendment reports 0 shares beneficially owned and 0.0% of the class. The filing lists issuer details, filer addresses, and includes a Joint Filing Agreement.

Key Figures

Form type: SCHEDULE 13G/A Beneficially owned: 0 shares Percent of class: 0.0% +2 more

5 metrics

Form type SCHEDULE 13G/A Amendment filing for beneficial ownership disclosure

Beneficially owned 0 shares Amount beneficially owned reported in Item 4

Percent of class 0.0% Percent of class reported in Item 4(b)

CUSIP 81684M104 Semler Scientific common stock identifier

Issuer address 51 E CAMPBELL AVE, CAMPBELL, CA 95008 Issuer principal executive offices listed in Item 1

Key Terms

Schedule 13G/A, Beneficially owned, Joint Filing Agreement

3 terms

Schedule 13G/A regulatory

"Amended Schedule 13G/A filed by Weiss Asset Management"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned financial

"Amount beneficially owned: 0 Weiss Asset Management is the sole investment manager"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Joint Filing Agreement regulatory

"Exhibit Information Joint Filing Agreement"

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Semler Scientific, Inc.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title of Class of Securities)

81684M104

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 81684M104

1

Names of Reporting Persons

Weiss Asset Management LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 81684M104

1

Names of Reporting Persons

WAM GP LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP Number(s): 81684M104

1

Names of Reporting Persons

WEISS ANDREW M

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Semler Scientific, Inc.
(b)	Address of issuer's principal executive offices: 51 E CAMPBELL AVE, CAMPBELL, CALIFORNIA, 95008
Item 2.
(a)	Name of person filing: (i) Weiss Asset Management LP ("Weiss Asset Management"). (ii) WAM GP LLC ("WAM GP"). (iii) Andrew M. Weiss, Ph.D. ("Andrew Weiss").
(b)	Address or principal business office or, if none, residence: Weiss Asset Management, WAM GP, and Andrew Weiss have a business address of 222 Berkeley St., 16th Floor, Boston, Massachusetts 02116.
(c)	Citizenship: (i) Weiss Asset Management is a Delaware limited partnership. (ii) WAM GP is a Delaware limited liability company. (iii) Andrew Weiss is a United States citizen.
(d)	Title of class of securities: Common Stock, $0.001 par value per share
(e)	CUSIP No.: 81684M104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0 Weiss Asset Management is the sole investment manager to a private investment partnership, ("the Partnership") and private investment funds ("Funds"). WAM GP is the sole general partner of Weiss Asset Management. Andrew Weiss is the managing member of WAM GP. Shares reported for WAM GP, Andrew Weiss and Weiss Asset Management include shares beneficially owned by the Partnership and the Funds. Each of WAM GP, Weiss Asset Management, and Andrew Weiss disclaims beneficial ownership of the shares reported herein as beneficially owned by each except to the extent of their respective pecuniary interest therein.
(b)	Percent of class: 0.0%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Item 4.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Weiss Asset Management LP

Signature:	Mary Merrigan
Name/Title:	Authorized Signatory
Date:	05/11/2026

WAM GP LLC

Signature:	Mary Merrigan
Name/Title:	Authorized Signatory
Date:	05/11/2026

WEISS ANDREW M

Signature:	Mary Merrigan
Name/Title:	Attorney-in-Fact for Andrew M. Weiss***
Date:	05/11/2026

Comments accompanying signature: ***Duly authorized under Power of Attorney incorporated herein by reference to the exhibit to the Form 13G/A filed by Weiss Asset Management LP on February 3, 2023 in respect of its holding in DEEP MEDICINE ACQUISITION CORP.

Exhibit Information

Joint Filing Agreement

FAQ

Does Weiss Asset Management own shares of SMLR?

No. The amended Schedule 13G/A states Weiss Asset Management, WAM GP LLC, and Andrew M. Weiss report 0 shares beneficially owned, representing 0.0% of Semler Scientific common stock as presented in the filing.

What filing did Weiss Asset Management submit for SMLR?

They filed an amended Schedule 13G/A. The document identifies the filers, the issuer (Semler Scientific, Inc.), the class (Common Stock, CUSIP 81684M104), and includes signature pages and a Joint Filing Agreement.

Who signed the Schedule 13G/A amendment for SMLR?

Mary Merrigan signed on behalf of the filers. The filing shows Mary Merrigan as Authorized Signatory and Attorney-in-Fact for Andrew M. Weiss, with signature dates shown in the amendment.

Does the filing indicate any voting or dispositive power over SMLR shares?

No voting or dispositive power is reported. The amendment shows 0 sole and 0 shared voting powers and 0 sole and 0 shared dispositive powers for the named filers.